AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Health Advance Inc.

$0 -$0.00 (-41.18%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
32.19K
AVG Volume
6.47M
Trailing/Forward PE
-2.93/-
PEG ratio
-0.03
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q30
26 Q20
26 Q10
25 Q40
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
Net Income (USD)
-60K-40K-20K024 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q3-50.31K
26 Q2-11.35K
26 Q1-14.64K
25 Q4-10.92K
25 Q2-11.1K
25 Q1-17.72K
24 Q4-11.61K
24 Q3-11.05K
24 Q2-11.52K
24 Q1-15.85K
Operating Income (USD)
-40K-30K-20K-10K024 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q3-30.12K
26 Q2-10.81K
26 Q1-14K
25 Q4-10.49K
25 Q2-10.54K
25 Q1-17.34K
24 Q4-10.27K
24 Q3-10.17K
24 Q2-10.24K
24 Q1-15.35K
EBITDA (USD)
-40K-30K-20K-10K024 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q3-30.12K
26 Q2-10.81K
26 Q1-14K
25 Q4-10.49K
25 Q2-10.54K
25 Q1-17.6K
24 Q4-11.04K
24 Q3-10.99K
24 Q2-11.01K
24 Q1-15.35K
Cash Flows (USD)
-300K-200K-100K023 Q223 Q323 Q424 Q124 Q224 Q325 Q426 Q126 Q226 Q3
HADV Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q3-41.92K
26 Q2-5.41K
26 Q1-3.66K
25 Q4-5.21K
24 Q3-579
24 Q2-966
24 Q1-7.92K
23 Q4-2.18K
23 Q3-9.25K
23 Q2-252.11K
EPS (USD)
-0-0-0-0-024 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV EPS (USD) by quarter
PeriodEPS (USD)
26 Q30
26 Q20
26 Q10
25 Q40
25 Q20
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0
Expenses (USD)
-10K010K20K30K40KSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q40
23 Q30
23 Q20
26 Q330.11K
26 Q210.8K
26 Q113.97K
25 Q410.46K
25 Q210.49K
25 Q117.3K
24 Q411K
24 Q310.94K
24 Q211.01K
24 Q115.35K
Cash & Debt (USD)
-100K0100K200K300K400KCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q31.28K
26 Q2-1.21K
26 Q1-1.19K
25 Q4-1.11K
25 Q2-585
25 Q1-316
24 Q4-155
24 Q3287
24 Q2830
24 Q11.1K
Debt ratios
-80-60-40-20024 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Debt ratios by quarter
PeriodDebt ratios
26 Q3-5.44
26 Q2-7.07
26 Q1-5.9
25 Q4-6.1
25 Q2-5.85
25 Q1-5.71
24 Q4-5.77
24 Q3-67.13
24 Q2-20.03
24 Q1-1.96
Margins
0%10%20%30%40%11 Q4
HADV Margins by quarter
PeriodMargins
11 Q431%
Return on Capital
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Return on Capital by quarter
PeriodReturn on Capital
26 Q327.4%
26 Q28.06%
26 Q112%
25 Q410.17%
25 Q213.46%
25 Q124.82%
24 Q421.63%
24 Q326.33%
24 Q237.26%
24 Q181.67%
Shares Outstanding
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Shares Outstanding by quarter
PeriodShares Outstanding
26 Q31.28B
26 Q21.16B
26 Q1955.82M
25 Q4714.99M
25 Q2455.04M
25 Q1339.54M
24 Q4204.37M
24 Q3185.95M
24 Q2185.95M
24 Q1185.95M
Book Value Per Share (USD)
-0-0-0-024 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q3-0
26 Q2-0
26 Q1-0
25 Q4-0
25 Q2-0
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0
Total Assets (USD)
0200K400K600K24 Q124 Q224 Q324 Q425 Q125 Q225 Q426 Q126 Q226 Q3
HADV Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q3504.51K
26 Q2503.75K
26 Q1503.77K
25 Q4499.88K
25 Q2500.41K
25 Q1500.68K
24 Q4500.84K
24 Q3501.28K
24 Q2501.82K
24 Q1502.1K
Employee Count
00.511.522012201320142015
HADV Employee Count by quarter
PeriodEmployee Count
20151
20141
20131
20121
Free Cash Flow Yield
-60%-40%-20%0%med -15.56%Mar 23Jun 23Oct 23Jan 24May 24Aug 24Sep 26
HADV Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-22.01%
Sep 26-22.01%
Aug 26-27.51%
Aug 26-22.01%
Aug 26-22.01%
Aug 26-22.01%
Jul 26-44.02%
Jul 26-22.01%
Jul 26-22.01%
Jul 26-22.01%
Jul 26-22.01%
Sep 24-6.96%
Sep 24-6.26%
Sep 24-5.96%
Sep 24-6.96%
Aug 24-7.83%
Aug 24-5.52%
Aug 24-5.22%
Aug 24-4.47%
Aug 24-2.32%
Jul 24-3.4%
Jul 24-2.98%
Jul 24-4.36%
Jul 24-2.98%
Jun 24-3.21%
Jun 24-5.75%
Jun 24-4.37%
Jun 24-2.06%
May 24-1.71%
May 24-1.5%
May 24-3.36%
May 24-4.2%
Apr 24-2.73%
Apr 24-9.11%
Apr 24-2.95%
Apr 24-2.8%
Mar 24-37.77%
Mar 24-36.5%
Mar 24-40.11%
Mar 24-24.74%
Feb 24-33.18%
Feb 24-32.26%
Feb 24-24.74%
Feb 24-24.74%
Jan 24-26.07%
Jan 24-26.3%
Jan 24-32.44%
Jan 24-32.44%
Dec 23-22.46%
Dec 23-4.58%
Dec 23-3.33%
Dec 23-3.66%
Dec 23-5.09%
Nov 23-5.09%
Nov 23-5.09%
Nov 23-5.09%
Nov 23-7.96%
Oct 23-5.09%
Oct 23-5.23%
Oct 23-5.23%
Oct 23-4.69%
Sep 23-4.26%
Sep 23-34.17%
Sep 23-31.94%
Sep 23-48.98%
Sep 23-48.98%
Aug 23-56.52%
Aug 23-44.53%
Aug 23-30.61%
Aug 23-29.39%
Jul 23-28.81%
Jul 23-31.77%
Jul 23-28.81%
Jul 23-28.26%
Jun 23-34.17%
Jun 23-33.7%
Jun 23-24.36%
Jun 23-29.58%
Jun 23-33.7%
May 23-42.62%
May 23-28.14%
May 23-27.87%
May 23-30.19%
Apr 23-24.56%
Apr 23-24.15%
Apr 23-24.56%
Apr 23-33.7%
Mar 23-31.51%
Mar 23-4.05%
Mar 23-4.2%
Mar 23-2.86%
Mar 23-2.65%
Feb 23-1.91%
Feb 23-2.2%
Feb 23-1.61%
Feb 23-2.86%
Jan 23-3.49%
Jan 23-2.75%
Jan 23-4.44%
Jan 23-2.6%
Price to Sales
680700720740med 735.6Nov 12Dec 12Dec 12Jan 13Feb 13Mar 13Mar 13
HADV Price to Sales by quarter
PeriodPrice to Sales
Mar 13735.6
Mar 13735.6
Mar 13735.6
Mar 13735.6
Feb 13735.6
Feb 13735.6
Feb 13735.6
Feb 13735.6
Jan 13735.6
Jan 13735.6
Jan 13735.6
Jan 13735.6
Dec 12735.6
Dec 12735.6
Dec 12682.78
Dec 12682.78
Nov 12682.78
Nov 12682.78
Nov 12682.78
EV/EBITDA
050100150200med 66.2Oct 22Nov 22Dec 22Dec 22Jan 23Feb 23Mar 23
HADV EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 2325.5
Mar 2324.83
Mar 2333.3
Mar 2335.42
Feb 2346.54
Feb 2341.25
Feb 2353.95
Feb 2333.3
Jan 2328.54
Jan 2334.36
Jan 2323.86
Jan 2335.95
Dec 2235.95
Dec 2278.44
Dec 2282.52
Dec 2282.78
Dec 22130.92
Nov 22130.92
Nov 22165.31
Nov 22130.92
Nov 22130.92
Oct 22110.51
Oct 22127.42
Oct 22130.92
Oct 22130.92
Sep 22119.25
Price to Book
050100150med 3.93Dec 21Apr 22Jul 22Nov 22Feb 23Jun 23Sep 23
HADV Price to Book by quarter
PeriodPrice to Book
Sep 23113.61
Sep 23121.53
Sep 2379.26
Sep 2379.26
Aug 2368.69
Aug 2387.19
Aug 23126.82
Aug 23132.1
Jul 23134.74
Jul 23122.19
Jul 23134.74
Jul 23137.39
Jun 23113.61
Jun 2328.98
Jun 2340.1
Jun 2333.02
Jun 2328.98
May 2322.91
May 2334.71
May 2335.04
May 2332.35
Apr 2339.76
Apr 2340.43
Apr 2339.76
Apr 2328.98
Mar 2331
Mar 234
Mar 233.86
Mar 235.67
Mar 236.12
Feb 238.5
Feb 237.37
Feb 2310.09
Feb 235.67
Jan 234.65
Jan 235.9
Jan 233.65
Jan 236.24
Dec 226.24
Dec 224.11
Dec 224.37
Dec 224.38
Dec 227.47
Nov 227.47
Nov 229.67
Nov 227.47
Nov 227.47
Oct 226.16
Oct 227.24
Oct 227.47
Oct 227.47
Sep 226.72
Sep 220.42
Sep 220.47
Sep 220.51
Sep 220.47
Aug 220.57
Aug 220.47
Aug 220.47
Aug 220.61
Jul 220.49
Jul 220.44
Jul 220.48
Jul 220.5
Jul 220.66
Jun 221.27
Jun 221.2
Jun 221.2
Jun 221.88
May 222.35
May 222.28
May 222.35
May 223.06
Apr 223.06
Apr 222.53
Apr 221.88
Apr 221.7
Apr 222.35
Mar 222.35
Mar 222.35
Mar 222.3
Mar 222.12
Feb 221.88
Feb 221.88
Feb 222.01
Feb 222.12
Jan 221.93
Jan 222.43
Jan 222.44
Jan 222.35
Dec 212.35
Dec 212.99
Dec 213.01
Dec 213.01
Dec 213.15
Nov 213.2
Nov 212.83
Nov 212.54
Nov 213.19
Oct 213.3
Health Advance Inc.
HADV
Stockpicker

Video analysis: HADV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.